Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BioCorRx Inc.BICX · Entity 8179 | Director | March 28, 2024 | April 03, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BioCorRx Inc.
Report date March 28, 2024 · Filed April 03, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $0.90 · Expires 2029-03-28 | Direct | 16,698 |
Reported balance
After 2024-03-28 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2024-03-28 · Grant · Acquired 16,698 · Balance 16,698 F1: On March 28, 2024, the issuer granted the reporting person an option that was 100% vested on issuance. |
Filing footnotes · ownership attribution and instrument terms
F1: On March 28, 2024, the issuer granted the reporting person an option that was 100% vested on issuance.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 28, 2024 Filed Apr 3, 2024 15:45 UTC | BioCorRx Inc. BICX · Entity 8179 | GrantStock Option · Derivative | 16,698 | $0.00 Strike: $0.90 | $0.00 |
DisclosureSEC source: 0001477932-24-001832 · form4.xml · derivative · entry 1 Granier Brady James · CIK 0001570636 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,698 Underlying: Common Stock · 16,698 shares Expires 2029-03-28 F1 · shares: On March 28, 2024, the issuer granted the reporting person an option that was 100% vested on issuance. Read SEC document |
| January 02, 2024 Filed Jan 4, 2024 21:59 UTC | BioCorRx Inc. BICX · Entity 8179 | GrantStock Option · Derivative | 18,519 | $0.00 Strike: $0.81 | $0.00 |
DisclosureSEC source: 0001477932-24-000042 · form4.xml · derivative · entry 1 Granier Brady James · CIK 0001570636 · Director · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,519 Underlying: Common Stock · 18,519 shares Expires 2029-01-02 F1 · shares: On January 2, 2024, the issuer granted the reporting person an option that was 100% vested on issuance. Read SEC document |
| September 29, 2023 Filed Oct 2, 2023 20:38 UTC | BioCorRx Inc. BICX · Entity 8179 | GrantStock Option · Derivative | 8,574 | $0.00 Strike: $1.75 | $0.00 |
DisclosureSEC source: 0001477932-23-007295 · primary_doc.xml · derivative · entry 1 Granier Brady James · CIK 0001570636 · Director · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,574 Underlying: Common Stock · 8,574 shares Expires 2028-09-29 F1 · shares: On September 29, 2023, the issuer granted the reporting person an option that was 100% vested on issuance. Read SEC document |
| June 30, 2023 Filed Jul 5, 2023 21:04 UTC | BioCorRx Inc. BICX · Entity 8179 | GrantStock Option · Derivative | 8,673 | $0.00 Strike: $1.73 | $0.00 |
DisclosureSEC source: 0001477932-23-005019 · form4.xml · derivative · entry 1 Granier Brady James · CIK 0001570636 · Director · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,673 Underlying: Common Stock · 8,673 shares Expires 2028-06-30 F1 · shares: On June 30, 2023, the issuer granted the reporting person an option that was 100% vested on issuance. Read SEC document |
| March 31, 2023 Filed Apr 3, 2023 22:29 UTC | BioCorRx Inc. BICX · Entity 8179 | GrantStock Option · Derivative | 8,472 | $0.00 Strike: $1.77 | $0.00 |
DisclosureSEC source: 0001477932-23-002225 · form4.xml · derivative · entry 1 Granier Brady James · CIK 0001570636 · Director · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,472 Underlying: Common Stock · 8,472 shares Expires 2028-03-31 F1 · shares: On March 31, 2023, the issuer granted the reporting person an option that was 100% vested on issuance. Read SEC document |
| December 30, 2022 Filed Jan 4, 2023 21:15 UTC | BioCorRx Inc. BICX · Entity 8179 | GrantStock Option · Derivative | 15,957 | $0.00 Strike: $0.94 | $0.00 |
DisclosureSEC source: 0001477932-23-000089 · form4.xml · derivative · entry 1 Granier Brady James · CIK 0001570636 · Director · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,957 Underlying: Common Stock · 15,957 shares Expires 2027-12-30 F1 · shares: On December 30, the issuer granted the reporting person an option that was 100% vested on issuance. Read SEC document |
| September 30, 2022 Filed Oct 5, 2022 20:08 UTC | BioCorRx Inc. BICX · Entity 8179 | GrantStock Option · Derivative | 7,350 | $0.00 Strike: $2.04 | $0.00 |
DisclosureSEC source: 0001477932-22-007470 · form4.xml · derivative · entry 1 Granier Brady James · CIK 0001570636 · Director · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,350 Underlying: Common Stock · 7,350 shares Expires 2027-09-30 F1 · shares: On September 30, 2022, the issuer granted the reporting person an option that was 100% vested on issuance. Read SEC document |
| June 30, 2022 Filed Jul 20, 2022 15:05 UTC | BioCorRx Inc. BICX · Entity 8179 | GrantStock Option · Derivative | 6,276 | $0.00 Strike: $2.39 | $0.00 |
DisclosureSEC source: 0001477932-22-005236 · form4.xml · derivative · entry 1 Granier Brady James · CIK 0001570636 · Director · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,276 Underlying: Common Stock · 6,276 shares Expires 2027-06-30 F1 · shares: On June 30, 2022, the issuer granted the reporting person an option that was 100% vested on issuance. Read SEC document |
| March 31, 2022 Filed Apr 4, 2022 22:46 UTC | BioCorRx Inc. BICX · Entity 8179 | GrantStock Option · Derivative | 4,224 | $0.00 Strike: $3.55 | $0.00 |
DisclosureSEC source: 0001477932-22-002044 · form4.xml · derivative · entry 1 Granier Brady James · CIK 0001570636 · Director · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,224 Underlying: Common Stock · 4,224 shares Expires 2027-03-31 F1 · shares: On March 31, 2022, the issuer granted the reporting person an option that was 100% vested on issuance. Read SEC document |
| February 11, 2022 Filed Feb 15, 2022 22:04 UTC | BioCorRx Inc. BICX · Entity 8179 | GrantNonqualified Stock Options (Right to Buy) · Derivative | 11,250 | $0.00 Strike: $4.01 | $0.00 |
DisclosureSEC source: 0001477932-22-000866 · form4.xml · derivative · entry 1 Granier Brady James · CIK 0001570636 · Director · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,250 Underlying: Common Stock · 11,250 shares Expires 2027-02-10 F1 · shares: On February 11, 2022, the issuer granted the reporting person an option that was 100% vested on issuance. Read SEC document |
| March 31, 2021 Filed Apr 2, 2021 15:50 UTC | BioCorRx Inc. BICX · Entity 8179 | GrantCommon Stock, par value $0.001 | 2,326 | $0.00 | $0.00 |
DisclosureSEC source: 0001477932-21-002002 · form4.xml · nonDerivative · entry 1 Granier Brady James · CIK 0001570636 · Director · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,301 F1 · kind: These shares were issued to Mr. Granier pursuant to a Director Agreement, dated March 1, 2019, by and between BioCorRx Inc. and Mr. Granier. As compensation for his services, Mr. Granier shall be issued, upon the last day of each fiscal quarter, provided Mr. Granier is a member of the Board as of such date, the number of shares of the Company's common stock equivalent to $5,000 as determined based on the average closing price on the three trading days immediately preceding the last day of such quarter. The average closing price on the three trading days immediately preceding the date of this transaction was $2.15. Read SEC document |
| September 30, 2020 Filed Oct 13, 2020 22:34 UTC | BioCorRx Inc. BICX · Entity 8179 | GrantCommon Stock, par value $0.001 | 2,631 | $0.00 | $0.00 |
DisclosureSEC source: 0001477932-20-005859 · form4.xml · nonDerivative · entry 1 Granier Brady James · CIK 0001570636 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,074 F1 · kind: These shares were issued to Mr. Granier pursuant to a Director Agreement, dated March 1, 2019, by and between BioCorRx Inc. and Mr. Granier. As compensation for his services, Mr. Granier shall be issued, upon the last day of each fiscal quarter, provided Mr. Granier is a member of the Board as of such date, the number of shares of the Company's common stock equivalent to $5,000 as determined based on the average closing price on the three trading days immediately preceding the last day of such quarter. The average closing price on the three trading days immediately preceding the date of this transaction was $1.90. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.